Visiting Vietnamese President Nguyen Xuan Phuc will hold a summit meeting with Korean President Yoon Suk-yeol in Seoul on Dec. 5. The meeting will be reportedly attended by the heads of major Korean conglomerates such as Samsung, Hyundai Motor, LG and Lotte. A large-scale economic delegation was inc
The authors are analysts of Shinhan Securities. They can be reached at shawn1225@shinhan.com and jhwon@shinhan.com, respectively. – Ed. US partner Spectrum receives CRL from FDA for poziotinibSpectrum Pharmaceuticals, Hanmi Pharm’s US partner for the non-small cell lung cancer treatment candidate po
The authors are analysts of Shinhan Securities. They can be reached at sehunjang@shinhan.com and shawn1225@shinhan.com, respectively. -- Ed. Time to price in the value of next-generation FcRn inhibitorHanall Biopharma’s recent share price trend suggests that the removal of uncertainty in the clinica
The South Korean government announced on Nov. 24 that the ratio of nuclear power generation to the total would be increased to 32.4 percent by 2030, renewable energy-based power generation would be increased to at least 100 GW by 2036, and the ratio of coal-based power generation would be reduced to
South Korean President Yoon Suk-yeol has requested Tesla CEO Elon Musk to build a Gigafactory in Korea, the President's Office said on Nov. 23.Musk responded by saying, “We are considering Korea as one of the top investment candidates.” Musk also expressed his will to invest in Korea’s electric
The U.S. state of Tennessee has emerged as a strong candidate site for LG Chem's planned cathode material plant in North America.LG Chem is considering building a cathode material plant on an area of about 1.69 million square meters in Clarksville, Tennessee, according to foreign media reports
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.co. -- Ed. SK Biopharm posted consolidated 3Q22 sales of W88.8bn and an operating loss of W9.2bn, beating consensus. The firm’s operating loss narrowed on the booking of W19.6bn in licensing out fees for Cenoba
Daewoong Pharmaceutical will launch a phase 1 clinical trial of a new drug for autoimmune diseases in the United States. It is a first-in-class medication in the autoimmune disease family that simultaneously inhibits two enzymes involved in immune cell activation. The clinical trial on 72 patients i
The author is an analyst of KB Securities. He can be reached at kimtaehee@kbfg.com. -- Ed. Slightly lower target price to KRW350,000 on WACC increase We slightly lower our TP (KRW380,000→KRW350,000) on Hanmi Pharm. While we revise up our earnings estimates to reflect 3Q22 results, we raise RFR to 3.
JW Group announced on Nov. 1 that it has signed a joint research contract with KURE.AI Therapeutics, a U.S. biotech venture company, to develop innovative anticancer therapies based on artificial intelligence (AI).Under this contract, JW Pharmaceutical and JW CreaGene will start R&D activities for t
JW Pharmaceutical announced on Oct. 31 that it will make a poster presentation on the results of a preclinical study on JW0061, a Wnt target hair loss treatment, at Wnt 2022, a conference to be held in Japan for five days from Nov. 15.Wnt is an acronym in the field of genetics that stands for 'W
Dong-A ST announced on Oct. 26 that it would purchase treasury stocks worth 10 billion won to enhance shareholder value.The stock repurchase plan will be implemented immediately beginning from Oct. 27. It will be carried out four times in a one-year period. The purchase method is a direct acquisitio
The authors are analysts of Shinhan Investment Corp. They can be reached at sehunjang@shinhan.com and shawn1225@shinhan.com, respectively. -- Ed. 3Q22 preview: Sales likely in line with market expectationsWe now expect Yuhan to post sales of KRW486.6bn (+7.8% YoY) for 3Q22, in line with the market c
The authors are analysts of KB Securities. They can be reached at kelee@kbfg.com and hdsung@kbfg.com, respectively. -- Ed. Maintain BUY; Revise down TP by 9.5% to KRW42,000 We maintain BUY on SaraminHR, but revise down target price by 9.5% to KRW42,000. We have revised down 2022E, 2023E, and 2024E N
Ontario, Canada's most populous province, has emerged as a strong candidate site for Samsung SDI’s second North American battery plant.Victor Anthony Fedeli, Ontario minister of economic development, job creation and trade, has recently met with Samsung SDI officials to discuss the construction
Korea’s defense exports are expected to reach an all-time high in 2022, with the export figure already topping US$10 billion, much more than the previous record of US$7 billion set in 2021.Exports to Poland drove the steep growth. The Polish government signed arms purchase contracts with Korean defe
Daewoong Pharmaceutical announced on Sept. 6 that it has launched the 4th class of the Daewoong Global Drug Delivery System (DDS) Training Program for talented students from Indonesia. A scholarship awarding ceremony was held at the Daewoong Pharmaceutical R&D Center on Sept. 5 with the attendance o
Samsung Biologics president John Rim has recently met with Eric Holcomb, governor of the U.S. State of Indiana who visited Korea, and discussed the company's potential investment in the U.S. state.Rim met with the governor on Aug. 26 at its plant in Songdo, Incheon. They discussed the current st
The authors are analysts of NH Investment & Securities. They can be reached at ys.jung@nhqv.com. -- Ed. Continued shelling on Ukraine’s Zaporizhzhia NPP raises the specter of the 1986 Chernobyl disaster.Zaporizhzhia NPP under attackThough having fallen to the Russian army in March, Ukraine’s Zaporiz
As the United States is in a hurry to strengthen its supply chains, Korean companies are accelerating their investments in North America. SK Group has recently announced a large-scale investment plan in North America. In a video interview with U.S. President Joe Biden in July, SK Group chairman Chey